Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: First Call Consensus rates PTSC a strong buy
Reply New Message
Back To Forum List View

First Call Consensus rates PTSC a strong buy

posted on Jan 25, 2009 03:04PM

I'm not sure when First Call started PTSC coverage but it was recently.

Storng Buy is their top rating.


2 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply